Phio Pharmaceuticals Statistics

Total Valuation

PHIO has a market cap or net worth of $11.27 million. The enterprise value is -$5.76 million.

Market Cap	11.27M
Enterprise Value	-5.76M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026, after market close.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

PHIO has 11.62 million shares outstanding. The number of shares has increased by 349.70% in one year.

Current Share Class	11.62M
Shares Outstanding	11.62M
Shares Change (YoY)	+349.70%
Shares Change (QoQ)	+24.13%
Owned by Insiders (%)	0.60%
Owned by Institutions (%)	10.82%
Float	11.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.68
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.32

Current Ratio	18.32
Quick Ratio	17.93
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -76.36% and return on invested capital (ROIC) is -50.27%.

Return on Equity (ROE)	-76.36%
Return on Assets (ROA)	-46.65%
Return on Invested Capital (ROIC)	-50.27%
Return on Capital Employed (ROCE)	-69.95%
Weighted Average Cost of Capital (WACC)	8.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.82M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.30% in the last 52 weeks. The beta is 0.81, so PHIO's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-55.30%
50-Day Moving Average	1.12
200-Day Moving Average	1.37
Relative Strength Index (RSI)	35.53
Average Volume (20 Days)	197,080

Short Selling Information

The latest short interest is 313,798, so 2.70% of the outstanding shares have been sold short.

Short Interest	313,798
Short Previous Month	331,567
Short % of Shares Out	2.70%
Short % of Float	2.72%
Short Ratio (days to cover)	2.24

Income Statement

Revenue	n/a
Gross Profit	-6.53M
Operating Income	-11.52M
Pretax Income	-10.93M
Net Income	-10.93M
EBITDA	-11.51M
EBIT	-11.52M
Earnings Per Share (EPS)	-$1.40

Full Income Statement

Balance Sheet

The company has $17.03 million in cash and n/a in debt, giving a net cash position of $17.03 million or $1.47 per share.

Cash & Cash Equivalents	17.03M
Total Debt	n/a
Net Cash	17.03M
Net Cash Per Share	$1.47
Equity (Book Value)	16.46M
Book Value Per Share	1.42
Working Capital	16.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.71 million and capital expenditures -$10,000, giving a free cash flow of -$10.72 million.

Operating Cash Flow	-10.71M
Capital Expenditures	-10,000
Depreciation & Amortization	3,500
Net Borrowing	n/a
Free Cash Flow	-10.72M
FCF Per Share	-$0.92

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-349.70%
Shareholder Yield	-349.70%
Earnings Yield	-97.01%
FCF Yield	-95.10%

Analyst Forecast

The average price target for PHIO is $14.00, which is 1,343.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	1,343.30%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on July 5, 2024. It was a reverse split with a ratio of 1:9.

Last Split Date	Jul 5, 2024
Split Type	Reverse
Split Ratio	1:9

Scores

Altman Z-Score	n/a
Piotroski F-Score	2